Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan A Adzhubei

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Nature Communications|April 19, 2023
DeMAG predicts the effects of variants in clinically actionable genes by integrating structural and evolutionary epistatic featuresFederica Luppino, Ivan A Adzhubei, Christopher A Cassa, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 28, 2022
Informing variant assessment using structured evidence from prior classifications (PS1, PM5, and PVS1 sequence variant interpretation criteria)Vineel Bhat, Ivan A Adzhubei, James D Fife, et al.
Plos Genetics|December 20, 2008
ErratumSteffen Schmidt, Anna Gerasimova, Fyodor A Kondrashov, et al.
Plos Genetics|December 2, 2008
Hypermutable non-synonymous sites are under stronger negative selectionSteffen Schmidt, Anna Gerasimova, Fyodor A Kondrashov, et al.
Nature|January 22, 2005
A universal trend of amino acid gain and loss in protein evolutionI King Jordan, Fyodor A Kondrashov, Ivan A Adzhubei, et al.
Nature Methods|April 1, 2010
A method and server for predicting damaging missense mutationsIvan A Adzhubei, Steffen Schmidt, Leonid Peshkin, et al.
Biomedicines|January 23, 2024
Carriers of Heterozygous Loss-of-Function ACE Mutations Are at Risk for Alzheimer's DiseaseSergei M Danilov, Ivan A Adzhubei, Alexander J Kozuch, et al.
Biomedicines|February 27, 2026
ACE-Dependent Alzheimer's Disease: Blood ACE Phenotyping of the Most Prevalent and Damaging <i>ACE</i> Missense Mutation-Y215C (rs3730025)Anastasiia A Buianova, Ivan A Adzhubei, Olga V Kryukova, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Nature Communications|April 19, 2023
DeMAG predicts the effects of variants in clinically actionable genes by integrating structural and evolutionary epistatic featuresFederica Luppino, Ivan A Adzhubei, Christopher A Cassa, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 28, 2022
Informing variant assessment using structured evidence from prior classifications (PS1, PM5, and PVS1 sequence variant interpretation criteria)Vineel Bhat, Ivan A Adzhubei, James D Fife, et al.
Plos Genetics|December 20, 2008
ErratumSteffen Schmidt, Anna Gerasimova, Fyodor A Kondrashov, et al.
Plos Genetics|December 2, 2008
Hypermutable non-synonymous sites are under stronger negative selectionSteffen Schmidt, Anna Gerasimova, Fyodor A Kondrashov, et al.
Nature|January 22, 2005
A universal trend of amino acid gain and loss in protein evolutionI King Jordan, Fyodor A Kondrashov, Ivan A Adzhubei, et al.
Nature Methods|April 1, 2010
A method and server for predicting damaging missense mutationsIvan A Adzhubei, Steffen Schmidt, Leonid Peshkin, et al.
Biomedicines|January 23, 2024
Carriers of Heterozygous Loss-of-Function ACE Mutations Are at Risk for Alzheimer's DiseaseSergei M Danilov, Ivan A Adzhubei, Alexander J Kozuch, et al.
Biomedicines|February 27, 2026
ACE-Dependent Alzheimer's Disease: Blood ACE Phenotyping of the Most Prevalent and Damaging <i>ACE</i> Missense Mutation-Y215C (rs3730025)Anastasiia A Buianova, Ivan A Adzhubei, Olga V Kryukova, et al.
Pageof 1